Učitavanje...
Dosage strategies for delaying resistance emergence in heterogeneous tumors
Drug resistance in cancer treatments is a frequent problem that, when it arises, leads to failure in therapeutic efforts. Tumor heterogeneity is the primary reason for resistance emergence and a precise treatment design that takes heterogeneity into account is required to postpone the rise of resist...
Spremljeno u:
| Izdano u: | FEBS Open Bio |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8091820/ https://ncbi.nlm.nih.gov/pubmed/33638275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/2211-5463.13129 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|